| scholarly article | Q13442814 |
| P50 | author | Tiny Jaarsma | Q40529350 |
| Dirk J van Veldhuisen | Q82060328 | ||
| Martje van der Wal | Q89322446 | ||
| Adriaan A Voors | Q91537232 | ||
| Hans L Hillege | Q91827926 | ||
| Vincent M van Deursen | Q114371803 | ||
| P2093 | author name string | Sven Meyer | |
| Peter van der Meer | |||
| P2860 | cites work | The CES-D Scale: A Self-Report Depression Scale for Research in the General Population | Q26778378 |
| Levels and determinants of inflammatory biomarkers in a Swiss population-based sample (CoLaus study) | Q28743795 | ||
| Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort | Q31056051 | ||
| Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). | Q31829434 | ||
| Heart failure in women: a need for prospective data | Q33488753 | ||
| Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload | Q33550675 | ||
| Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction | Q34528187 | ||
| Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment | Q34664894 | ||
| Representation of the elderly, women, and minorities in heart failure clinical trials | Q34769936 | ||
| Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis | Q34935593 | ||
| Timing and determinants of erythropoietin deficiency in chronic kidney disease | Q35692480 | ||
| Gender and heart failure: a population perspective | Q35771154 | ||
| Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms | Q36378447 | ||
| Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). | Q36415085 | ||
| Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community | Q36489384 | ||
| Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes | Q36625615 | ||
| Variations in serum transforming growth factor-beta1 levels with gender, age and lifestyle factors of healthy Japanese adults | Q37327123 | ||
| Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study | Q37588805 | ||
| Sex-related differences in myocardial remodeling. | Q37707569 | ||
| Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). | Q38392232 | ||
| Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmö preventive project | Q39876815 | ||
| Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure | Q40529264 | ||
| Gender differences in cardiac dysfunction and remodeling due to volume overload | Q43071725 | ||
| Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes | Q43256621 | ||
| Gender differences in advanced heart failure: insights from the BEST study | Q44697046 | ||
| Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial | Q44835795 | ||
| Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice | Q45027744 | ||
| Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction | Q45206840 | ||
| Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations | Q46071688 | ||
| Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population | Q46506451 | ||
| Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA. | Q46661139 | ||
| Body mass index, diabetes, and C-reactive protein among U.S. adults | Q46780760 | ||
| Impact of age and sex on plasma natriuretic peptide levels in healthy adults | Q48541147 | ||
| Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction | Q48599489 | ||
| Depressive symptoms and inflammation in patients hospitalized for heart failure | Q48857866 | ||
| Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. | Q50862918 | ||
| Where are all the women with heart failure? | Q50925620 | ||
| Gender-associated differences in left ventricular geometry in patients with aortic valve disease and effect of distinct overload subsets. | Q50936758 | ||
| Relation between gender, etiology and survival in patients with symptomatic heart failure. | Q50985635 | ||
| The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: Depressed and Positive Affect in cancer patients and healthy reference subjects. | Q51066906 | ||
| Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis | Q51354368 | ||
| Vitamin D status and outcomes in heart failure patients. | Q51467888 | ||
| Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. | Q51750239 | ||
| The influence of age, gender, and race on the prevalence of depression in heart failure patients. | Q53344736 | ||
| Influence of gender on the response to hemodynamic overload after myocardial infarction. | Q53955240 | ||
| Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction | Q57259626 | ||
| The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure | Q57315233 | ||
| Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart Failure | Q57396315 | ||
| Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II | Q57422693 | ||
| Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure | Q57422717 | ||
| Elevated C-reactive protein levels in overweight and obese adults | Q57830181 | ||
| P433 | issue | 32 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 2538-2547 | |
| P577 | publication date | 2013-05-10 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Neurohormonal and clinical sex differences in heart failure. | |
| P478 | volume | 34 |
| Q38222370 | Biomarkers for risk prediction in acute decompensated heart failure |
| Q38543356 | Cardiovascular biomarkers and sex: the case for women |
| Q38934239 | Decision Making Among Persons Living With Heart Failure |
| Q34836097 | Emerging biomarkers in heart failure and cardiac cachexia |
| Q39148919 | Endothelial Glycocalyx as Biomarker for Cardiovascular Diseases: Mechanistic and Clinical Implications |
| Q28550541 | GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia |
| Q47571604 | Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women? |
| Q95338257 | Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player |
| Q38182010 | Heart failure highlights in 2012-2013. |
| Q35390480 | Heart failure in a cohort of patients with chronic kidney disease: the GCKD study |
| Q47142903 | Is There a Sex-Related Difference in the Obesity Paradox in Systolic Heart Failure? Sex-Related Difference in the Obesity Paradox. |
| Q47191844 | Mechanotransduction Mechanisms in Mitral Valve Physiology and Disease Pathogenesis. |
| Q59136983 | Passive Stiffness of Left Ventricular Myocardial Tissue Is Reduced by Ovariectomy in a Post-menopause Mouse Model |
| Q37032185 | Periostin expression induced by oxidative stress contributes to myocardial fibrosis in a rat model of high salt-induced hypertension. |
| Q38606050 | Poor acute outcome in congestive heart failure is associated with increases in the plasma static oxidation-reduction potentials (sORP) in men but not in women |
| Q90181215 | Sex Differences in Circulating Biomarkers of Cardiovascular Disease |
| Q56977984 | Sex Differences in the Central and Peripheral Manifestations of Ischemia-induced Heart Failure in Rats |
| Q38751037 | Sex differences in cardiovascular ageing |
| Q50944234 | Sex differences in clinical characteristics and long-term outcome in acute decompensated heart failure patients with preserved and reduced ejection fraction. |
| Q37714568 | Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study |
| Q58733510 | Sex differences in ischemic heart disease and heart failure biomarkers |
| Q51076830 | Sex differences in new-onset heart failure. |
| Q90706189 | Sex-related differences in contemporary biomarkers for heart failure: a review |
Search more.